Addressing the wellbeing of this health brand in Australia
WIn the absence of guidelines for a new GlaxoSmithKline brand developed in the UK, came a pressing need to ensure its appropriate and consistent application on buildings in Australia including information and wayfinding signs, while adhering to a critical rollout schedule.